Metoprolol tartrate and Atorvastatin calcium drug interactions - from FDA reports

Summary

Drug interactions are reported among people who take Metoprolol tartrate and Atorvastatin calcium together. This study is created by eHealthMe based on reports of 1,565 people who take Metoprolol tartrate and Atorvastatin calcium from FDA, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on metoprolol tartrate and atorvastatin calcium (the active ingredients of Metoprolol tartrate and Atorvastatin calcium, respectively), and Metoprolol tartrate and Atorvastatin calcium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

What is Metoprolol tartrate?

Metoprolol tartrate has active ingredients of metoprolol tartrate. It is often used in high blood pressure. (latest outcomes from Metoprolol tartrate 59,602 users)

What is Atorvastatin calcium?

Atorvastatin calcium has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. (latest outcomes from Atorvastatin calcium 34,006 users)

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 10, 2019

1,565 people who take Metoprolol tartrate, Atorvastatin calcium are studied.


Number of reports submitted per year:

Metoprolol tartrate and Atorvastatin calcium drug interactions.

Most common drug interactions over time *:

< 1 month:
  1. Chest pain
  2. Renal impairment (severely reduced kidney function)
  3. Hypotension (abnormally low blood pressure)
  4. Bradycardia (abnormally slow heart action)
  5. Fatigue (feeling of tiredness)
  6. Blood glucose increased
  7. Acute myocardial infarction (acute heart attack)
  8. Angina pectoris (chest pain due to ischemia of the heart muscle)
  9. Atrioventricular block complete (heart block complete)
  10. Cardiac failure
1 - 6 months:
  1. Weight decreased
  2. Asthenia (weakness)
  3. Depression
  4. Pain
  5. Pneumonia
  6. Activities of daily living impaired
  7. Allergic granulomatous angiitis (allergic inflammation of a blood vessel or lymph duct)
  8. Anxiety
  9. Asthma
  10. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
6 - 12 months:
  1. Muscle spasms (muscle contraction)
  2. Muscular weakness (muscle weakness)
  3. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  4. Nausea (feeling of having an urge to vomit)
  5. Purpura (purplish discoloration of the skin)
  6. Pyrexia (fever)
  7. Tooth infection
  8. Vision blurred
  9. Weight decreased
  10. Weight increased
1 - 2 years:
  1. Arthralgia (joint pain)
  2. Myalgia (muscle pain)
  3. Affective disorder (mental disorder)
  4. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  5. Antisocial personality disorder
  6. Anxiety
  7. Anxiety disorder
  8. Constipation
  9. Decreased appetite
  10. Depression
2 - 5 years:
  1. Rash
  2. Aspartate aminotransferase increased
  3. Blood creatine phosphokinase increased
  4. Blood lactate dehydrogenase increased
  5. Condition
  6. Muscle atrophy (a decrease in the mass of the muscle)
  7. Muscle necrosis (muscle cell damage)
  8. Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously)
5 - 10 years:
  1. Dysphagia (condition in which swallowing is difficult or painful)
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  3. Weight decreased
  4. Weight increased
  5. Pneumonia
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Cough
  8. Depression
  9. Fatigue (feeling of tiredness)
  10. Lichen planus (an inflammatory skin condition, characterized by an itchy, non-infectious rash)
10+ years:

n/a

not specified:
  1. Diarrhoea
  2. Dyspnoea (difficult or laboured respiration)
  3. Fatigue (feeling of tiredness)
  4. Dizziness
  5. Nausea (feeling of having an urge to vomit)
  6. Constipation
  7. Weight decreased
  8. Asthenia (weakness)
  9. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  10. Hypotension (abnormally low blood pressure)

Most common drug interactions by gender *:

female:
  1. Constipation
  2. Headache (pain in head)
  3. Pneumonia
  4. Drug ineffective
  5. Weight decreased
  6. Decreased appetite
  7. Chest pain
  8. Vomiting
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Pyrexia (fever)
male:
  1. Diarrhoea
  2. Dyspnoea (difficult or laboured respiration)
  3. Pneumonia
  4. Nausea (feeling of having an urge to vomit)
  5. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Dysgeusia (disorder of the sense of taste)
  8. Abdominal pain upper
  9. Death
  10. Chest pain

Most common drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:
  1. Abortion induced (medically referred abortion)
  2. Cardiac arrest
  3. Dermatitis allergic (inflammation of the skin due allergic reaction)
  4. Drug exposure before pregnancy
30-39:
  1. Abdominal pain
  2. Blood creatinine increased
  3. Diarrhoea
  4. Nausea (feeling of having an urge to vomit)
  5. Adult respiratory distress syndrome (type of lung (pulmonary) failure)
  6. Anoxia (low oxygen)
  7. Anxiety
  8. Binocular eye movement disorder
  9. Colonic perforation (a hole in the colon)
  10. Condition
40-49:
  1. Bradycardia (abnormally slow heart action)
  2. Hypotension (abnormally low blood pressure)
  3. Hyperhidrosis (abnormally increased sweating)
  4. Diarrhoea
  5. Dizziness
  6. Drug clearance decreased
  7. Memory impairment
  8. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  9. Renal failure (kidney dysfunction)
  10. Tremor (trembling or shaking movements in one or more parts of your body)
50-59:
  1. Diarrhoea
  2. Dizziness
  3. Nausea (feeling of having an urge to vomit)
  4. Pain in extremity
  5. Peripheral swelling
  6. Pyrexia (fever)
  7. Anaemia (lack of blood)
  8. Burning sensation
  9. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  10. Hypotension (abnormally low blood pressure)
60+:
  1. Diarrhoea
  2. Dyspnoea (difficult or laboured respiration)
  3. Cardiac failure congestive
  4. Hypotension (abnormally low blood pressure)
  5. Haemoglobin decreased
  6. Chest pain
  7. Fall
  8. Pyrexia (fever)
  9. Headache (pain in head)
  10. Decreased appetite

* Approximation only. Some reports may have incomplete information.

Do you take Metoprolol tartrate and Atorvastatin calcium?


You are not alone:




Related publications that referenced our studies


Results from eHealthMe (non-FDA) reports of taking Metoprolol tartrate and Atorvastatin calcium together

Drug effectiveness (drug is found to be effective) over time *:
Metoprolol tartrate:
  • < 1 month: 0.0% (0 of 0 people)
  • 1 - 6 months: 30% (3 of 10 people)
  • 6 - 12 months: 71% (5 of 7 people)
  • 1 - 2 years: 50% (4 of 8 people)
  • 2 - 5 years: 61% (11 of 18 people)
  • 5 - 10 years: 73% (11 of 15 people)
  • 10+ years: 66% (4 of 6 people)
  • not specified: 0.0% (0 of 0 people)
Atorvastatin calcium:
  • < 1 month: 0.0% (0 of 0 people)
  • 1 - 6 months: 0.0% (0 of 12 people)
  • 6 - 12 months: 70% (7 of 10 people)
  • 1 - 2 years: 44% (4 of 9 people)
  • 2 - 5 years: 63% (7 of 11 people)
  • 5 - 10 years: 66% (6 of 9 people)
  • 10+ years: 57% (4 of 7 people)
  • not specified: 100% (1 of 1 people)
Drug effectiveness (drug is found to be effective) by gender *:
Metoprolol tartrate:
  • female: 68% (20 of 29 people)
  • male: 51% (18 of 35 people)
Atorvastatin calcium:
  • female: 44% (13 of 29 people)
  • male: 53% (16 of 30 people)
Drug effectiveness (drug is found to be effective) by age *:
Metoprolol tartrate:
  • 0-1: 0.0% (0 of 0 people)
  • 2-9: 0.0% (0 of 0 people)
  • 10-19: 0.0% (0 of 0 people)
  • 20-29: 0.0% (0 of 0 people)
  • 30-39: 0.0% (0 of 0 people)
  • 40-49: 75.0% (6 of 8 people)
  • 50-59: 70.0% (12 of 17 people)
  • 60+: 51.0% (20 of 39 people)
Atorvastatin calcium:
  • 0-1: 0.0% (0 of 0 people)
  • 2-9: 0.0% (0 of 0 people)
  • 10-19: 0.0% (0 of 0 people)
  • 20-29: 0.0% (0 of 0 people)
  • 30-39: 0.0% (0 of 0 people)
  • 40-49: 40.0% (2 of 5 people)
  • 50-59: 42.0% (6 of 14 people)
  • 60+: 52.0% (21 of 40 people)
Race of the people *:
  • African American, Non-Hispanic: 0.58 %
  • American Indian/Alaska Native: 0.0 %
  • Asian: 0.58 %
  • Hispanic: 5.2 %
  • Native Hawaiians/Pacific Islanders: 0.0 %
  • Two or more races: 1.73 %
  • White, Non-Hispanic: 91.91 %

* Approximation only.


Related studies

Browse interactions by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Interactions between Metoprolol tartrate and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Atorvastatin calcium and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Metoprolol tartrate and Atorvastatin calcium
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Metoprolol tartrate and Atorvastatin calcium (63,659 reports studied)



FDA reports used in this study


Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!